Viral Pneumonia and Acute Respiratory Distress Syndrome

Overview

Journal Clin Chest Med

Specialty Pulmonary Medicine

Date 2017 Feb 5

PMID 28159154

Citations 38

Authors

Raj D Shah

Richard G Wunderink

Affiliations

Soon will be listed here.

Abstract

Respiratory viruses are a common cause of severe pneumonia and acute respiratory distress syndrome (ARDS) in adults. The advent of new diagnostic technologies, particularly multiplex reverse transcription polymerase chain reaction, have increased the recognition of viral respiratory infections in critically ill adults. Supportive care for adults with ARDS caused by respiratory viruses is similar to the care of patients with ARDS from other causes. Although antiviral therapy is available for some respiratory viral infections, further research is needed to determine which groups of patients would benefit.

Citing Articles

Ameliorating lipopolysaccharide induced acute lung injury with Lianhua Qingke: focus on pulmonary endothelial barrier protection.

Ma Y, Hou Y, Han Y, Liu Y, Han N, Yin Y J Thorac Dis. 2024; 16(10):6899-6917.

PMID: 39552861 PMC: 11565356. DOI: 10.21037/jtd-24-700.

Beneficial effect of sequential treatment with high-dose steroids and short-course oral glucocorticoids in patients with severe influenza virus-associated pneumonia.

Li W, Gao M, Hao Y, Chi H, Yu J Sci Rep. 2024; 14(1):25023.

PMID: 39443650 PMC: 11499680. DOI: 10.1038/s41598-024-76400-2.

Lessons Learned from the Lived Experiences of COVID-19 ICU Survivors Who are Struggling Through Critical Conditions and Surviving to Champion Life: A Qualitative Study.

Trisyani Y, Mahendra D, Nuraeni A J Multidiscip Healthc. 2024; 17:2659-2669.

PMID: 38828267 PMC: 11141573. DOI: 10.2147/JMDH.S380389.

Predicting the potentially exacerbation of severe viral pneumonia in hospital by MuLBSTA score joint CD4 + and CD8 +T cell counts: construction and verification of risk warning model.

Chen X, Ma B, Yang Y, Zhang M, Xu F BMC Pulm Med. 2024; 24(1):261.

PMID: 38811907 PMC: 11137986. DOI: 10.1186/s12890-024-03073-y.

Antiviral responses versus virus-induced cellular shutoff: a game of thrones between influenza A virus NS1 and SARS-CoV-2 Nsp1.

Khalil A, Nogales A, Martinez-Sobrido L, Mostafa A Front Cell Infect Microbiol. 2024; 14:1357866.

PMID: 38375361 PMC: 10875036. DOI: 10.3389/fcimb.2024.1357866.

References

Frieman M, Yount B, Agnihothram S, Page C, Donaldson E, Roberts A . Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease. J Virol. 2011; 86(2):884-97. PMC: 3255850. DOI: 10.1128/JVI.05957-11. View

Heneghan C, Onakpoya I, Thompson M, Spencer E, Jones M, Jefferson T . Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ. 2014; 348:g2547. PMC: 3981976. DOI: 10.1136/bmj.g2547. View

Davies A, Jones D, Bailey M, Beca J, Bellomo R, Blackwell N . Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA. 2009; 302(17):1888-95. DOI: 10.1001/jama.2009.1535. View

Manocha S, Walley K, Russell J . Severe acute respiratory distress syndrome (SARS): a critical care perspective. Crit Care Med. 2003; 31(11):2684-92. DOI: 10.1097/01.CCM.0000091929.51288.5F. View

Moscona A, Porotto M, Palmer S, Tai C, Aschenbrenner L, Triana-Baltzer G . A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo. J Infect Dis. 2010; 202(2):234-41. PMC: 2891144. DOI: 10.1086/653621. View

Donnelly C, Fisher M, Fraser C, Ghani A, Riley S, Ferguson N . Epidemiological and genetic analysis of severe acute respiratory syndrome. Lancet Infect Dis. 2004; 4(11):672-83. PMC: 7106498. DOI: 10.1016/S1473-3099(04)01173-9. View

Schildgen V, van den Hoogen B, Fouchier R, Tripp R, Alvarez R, Manoha C . Human Metapneumovirus: lessons learned over the first decade. Clin Microbiol Rev. 2011; 24(4):734-54. PMC: 3194831. DOI: 10.1128/CMR.00015-11. View

de Groot R, Baker S, Baric R, Brown C, Drosten C, Enjuanes L . Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol. 2013; 87(14):7790-2. PMC: 3700179. DOI: 10.1128/JVI.01244-13. View

Gross A, Bryson M . Oral Ribavirin for the Treatment of Noninfluenza Respiratory Viral Infections: A Systematic Review. Ann Pharmacother. 2015; 49(10):1125-35. DOI: 10.1177/1060028015597449. View

10.

Zhan Y, Yang Z, Chen R, Wang Y, Guan W, Zhao S . Respiratory virus is a real pathogen in immunocompetent community-acquired pneumonia: comparing to influenza like illness and volunteer controls. BMC Pulm Med. 2014; 14:144. PMC: 4236731. DOI: 10.1186/1471-2466-14-144. View

11.

Papadopoulos N, Bates P, Bardin P, Papi A, Leir S, Fraenkel D . Rhinoviruses infect the lower airways. J Infect Dis. 2000; 181(6):1875-84. DOI: 10.1086/315513. View

12.

Amato M, Barbas C, Medeiros D, Magaldi R, Schettino G, Lorenzi-Filho G . Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med. 1998; 338(6):347-54. DOI: 10.1056/NEJM199802053380602. View

13.

Guerin C, Reignier J, Richard J, Beuret P, Gacouin A, Boulain T . Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013; 368(23):2159-68. DOI: 10.1056/NEJMoa1214103. View

14.

Hong H, Hong S, Ko G, Huh J, Sung H, Do K . Viral infection is not uncommon in adult patients with severe hospital-acquired pneumonia. PLoS One. 2014; 9(4):e95865. PMC: 3994115. DOI: 10.1371/journal.pone.0095865. View

15.

Hamelin M, Prince G, Boivin G . Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection. Antimicrob Agents Chemother. 2006; 50(2):774-7. PMC: 1366914. DOI: 10.1128/AAC.50.2.774-777.2006. View

16.

Hayden F, Albrecht J, Kaiser D, Gwaltney Jr J . Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon. N Engl J Med. 1986; 314(2):71-5. DOI: 10.1056/NEJM198601093140202. View

17.

Brower R, Matthay M, Morris A, Schoenfeld D, Thompson B, Wheeler A . Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000; 342(18):1301-8. DOI: 10.1056/NEJM200005043421801. View

18.

Walsh E, Peterson D, Falsey A . Is clinical recognition of respiratory syncytial virus infection in hospitalized elderly and high-risk adults possible?. J Infect Dis. 2007; 195(7):1046-51. DOI: 10.1086/511986. View

19.

Correa T, Sanches P, Morais L, Scarin F, Silva E, Barbas C . Performance of noninvasive ventilation in acute respiratory failure in critically ill patients: a prospective, observational, cohort study. BMC Pulm Med. 2015; 15:144. PMC: 4642766. DOI: 10.1186/s12890-015-0139-3. View

20.

. Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial. BMJ. 2013; 346:f3039. PMC: 3668094. DOI: 10.1136/bmj.f3039. View